159 related articles for article (PubMed ID: 8861754)
1. Tenascin and type IV collagen expression in liver cell dysplasia and in hepatocellular carcinoma.
Zhao M; Laissue JA; Zimmermann A
Histol Histopathol; 1996 Apr; 11(2):323-33. PubMed ID: 8861754
[TBL] [Abstract][Full Text] [Related]
2. Extracellular matrix composition and integrin expression in early hepatocarcinogenesis in human cirrhotic liver.
Le Bail B; Faouzi S; Boussarie L; Balabaud C; Bioulac-Sage P; Rosenbaum J
J Pathol; 1997 Mar; 181(3):330-7. PubMed ID: 9155721
[TBL] [Abstract][Full Text] [Related]
3. Three types of liver cell dysplasia (LCD) in small cirrhotic nodules are distinguishable by karyometry and PCNA labelling, and their features resemble distinct grades of hepatocellular carcinoma.
Zhao M; Zhang NX; Du ZY; Laissue JA; Zimmermann A
Histol Histopathol; 1994 Jan; 9(1):73-83. PubMed ID: 7911690
[TBL] [Abstract][Full Text] [Related]
4. Liver cell dysplasia: reactivities for c-met protein, Rb protein, E-cadherin and transforming growth factor-beta 1 in comparison with hepatocellular carcinoma.
Zhao M; Zimmermann A
Histol Histopathol; 1998 Jul; 13(3):657-70. PubMed ID: 9690121
[TBL] [Abstract][Full Text] [Related]
5. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
[TBL] [Abstract][Full Text] [Related]
6. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
[TBL] [Abstract][Full Text] [Related]
7. Macroregenerative nodules in a series of adult cirrhotic liver explants: issues of classification and nomenclature.
Hytiroglou P; Theise ND; Schwartz M; Mor E; Miller C; Thung SN
Hepatology; 1995 Mar; 21(3):703-8. PubMed ID: 7875667
[TBL] [Abstract][Full Text] [Related]
8. Distribution of cytokeratin 19-positive biliary cells in cirrhotic nodules, hepatic borderline nodules (atypical adenomatous hyperplasia), and small hepatocellular carcinomas.
Terada T; Hoso M; Nakanuma Y
Mod Pathol; 1995 May; 8(4):371-9. PubMed ID: 7567933
[TBL] [Abstract][Full Text] [Related]
9. Cell biological evaluation of liver cell carcinoma, dysplasia and adenoma by tissue micro-array analysis.
van Dekken H; Verhoef C; Wink J; van Marion R; Vissers KJ; Hop WC; de Man RA; IJzermans JN; van Eijck CH; Zondervan PE
Acta Histochem; 2005; 107(3):161-71. PubMed ID: 16000213
[TBL] [Abstract][Full Text] [Related]
10. Liver cell dysplasia and hepatocellular carcinoma in non-A, non-B hepatitis.
Lefkowitch JH; Apfelbaum TF
Arch Pathol Lab Med; 1987 Feb; 111(2):170-3. PubMed ID: 3028314
[TBL] [Abstract][Full Text] [Related]
11. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
Szczepański W
Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
[TBL] [Abstract][Full Text] [Related]
12. A clinicopathological study of the expression of extracellular matrix components in urothelial carcinoma.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Salmas M; Malamou-Mitsi V
BJU Int; 2005 Mar; 95(4):655-9. PubMed ID: 15705098
[TBL] [Abstract][Full Text] [Related]
13. Detection of micronuclei formation and nuclear anomalies in regenerative nodules of human cirrhotic livers and relationship to hepatocellular carcinoma.
de Almeida TM; Leitão RC; Andrade JD; Beçak W; Carrilho FJ; Sonohara S
Cancer Genet Cytogenet; 2004 Apr; 150(1):16-21. PubMed ID: 15041218
[TBL] [Abstract][Full Text] [Related]
14. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
15. Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas.
Okamura N; Yoshida M; Shibuya A; Sugiura H; Okayasu I; Ohbu M
Pathol Int; 2005 Nov; 55(11):724-31. PubMed ID: 16271085
[TBL] [Abstract][Full Text] [Related]
16. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
17. Liver cell dysplasia in alpha-1-antitrypsin deficiency.
Cohen C; Derose PB
Mod Pathol; 1994 Jan; 7(1):31-6. PubMed ID: 8159650
[TBL] [Abstract][Full Text] [Related]
18. Fine-needle aspiration cytology to distinguish dysplasia from hepatocellular carcinoma with different grades.
Lin CC; Lin CJ; Hsu CW; Chen YC; Chen WT; Lin SM
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e146-52. PubMed ID: 17532784
[TBL] [Abstract][Full Text] [Related]
19. Vascular density and VEGF expression in hepatic lesions.
Brodsky SV; Mendelev N; Melamed M; Ramaswamy G
J Gastrointestin Liver Dis; 2007 Dec; 16(4):373-7. PubMed ID: 18193117
[TBL] [Abstract][Full Text] [Related]
20. The application of image analysis and neural network technology to the study of large-cell liver-cell dysplasia and hepatocellular carcinoma.
An CS; Petrovic LM; Reyter I; Tolmachoff T; Ferrell LD; Thung SN; Geller SA; Marchevsky AM
Hepatology; 1997 Nov; 26(5):1224-31. PubMed ID: 9362366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
